SIMPLEXA™ DENGUE - COFEPRIS Registration 1523R2019 SSA
Access comprehensive regulatory information for SIMPLEXA™ DENGUE (SIMPLEXA™ DENGUE) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1523R2019 SSA and manufactured by DIASORIN MÉXICO S.A. DE C.V.. The device was registered on August 01, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
LA PRUEBA SIMPLEXATM DENGUE DE DIASORIN MOLECULAR ES UN ENSAYO DE REACCIÓN EN CADENA DE LA POLIMERASA EN TIEMPO REAL (RTPCR) QUE ESTÁ DESTINADO A SU USO EN EL EQUIPO LIAISON® MDX PARA LA DETECCIÓN IN VITRO Y TIPIFICACIÓN DE LOS SEROTIPOS 1, 2, 3 Y 4 DEL V
THE MOLECULAR DIASORIN DENGUE SIMPLEXATM TEST IS A REAL-TIME POLYMERASE CHAIN REACTION (RTPCR) ASSAY THAT IS INTENDED FOR USE IN LIAISON® MDX EQUIPMENT FOR IN VITRO DETECTION AND TYPING OF V SEROTYPES 1, 2, 3 AND 4